Healthcare provider profile · identity verified

Mushfeka Sharif, M.D.

Internal Medicine · YUBA CITY, CA · NPI 1699931584

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	546	145
Atorvastatin Calcium	Atorvastatin Calcium	491	147
Amlodipine Besylate	Amlodipine Besylate	399	113
Omeprazole	Omeprazole	290	88
Lisinopril	Lisinopril	266	75
Gabapentin	Gabapentin	263	76
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	245	47
Losartan Potassium	Losartan Potassium	240	66
Simvastatin	Simvastatin	233	70
Fluticasone Propionate	Fluticasone Propionate	193	80
Metformin Hcl	Metformin Hcl	186	55
Azelastine Hcl	Azelastine Hcl	148	67
Rosuvastatin Calcium	Rosuvastatin Calcium	148	48
Trazodone Hcl	Trazodone Hcl	135	39
Pantoprazole Sodium	Pantoprazole Sodium	131	40
Hydrochlorothiazide	Hydrochlorothiazide	126	35
Albuterol Sulfate Hfa	Albuterol Sulfate	121	54
Duloxetine Hcl	Duloxetine Hcl	120	31
Sertraline Hcl	Sertraline Hcl	120	35
Zolpidem Tartrate	Zolpidem Tartrate	114	23
Tamsulosin Hcl	Tamsulosin Hcl	112	34
Eliquis	Apixaban	110	27
Escitalopram Oxalate	Escitalopram Oxalate	99	25
Famotidine	Famotidine	99	29
Atenolol	Atenolol	97	27
Metoprolol Succinate	Metoprolol Succinate	93	30
Pravastatin Sodium	Pravastatin Sodium	89	28
Montelukast Sodium	Montelukast Sodium	88	25
Alendronate Sodium	Alendronate Sodium	87	27
Jardiance	Empagliflozin	78	13
Ezetimibe	Ezetimibe	75	23
Baclofen	Baclofen	73	24
Furosemide	Furosemide	71	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	22
Metformin Hcl Er	Metformin Hcl	68	20
Bupropion Xl	Bupropion Hcl	66	20
Citalopram Hbr	Citalopram Hydrobromide	64	15
Alprazolam	Alprazolam	62	29
Ozempic	Semaglutide	59	12
Carvedilol	Carvedilol	56	19
Diclofenac Sodium	Diclofenac Sodium	56	23
Spironolactone	Spironolactone	56	18
Meloxicam	Meloxicam	55	17
Triamcinolone Acetonide	Triamcinolone Acetonide	54	27
Lorazepam	Lorazepam	53	17
Oxycodone Hcl	Oxycodone Hcl	53	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	51	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	50	14
Synthroid	Levothyroxine Sodium	49	14
Donepezil Hcl	Donepezil Hcl	48	suppressed
Potassium Chloride	Potassium Chloride	48	20
Carisoprodol	Carisoprodol	46	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	14
Temazepam	Temazepam	44	suppressed
Allopurinol	Allopurinol	42	14
Amitriptyline Hcl	Amitriptyline Hcl	42	11
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Glipizide Er	Glipizide	42	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	14
Januvia	Sitagliptin Phosphate	41	suppressed
Ondansetron Odt	Ondansetron	41	23
Estradiol	Estradiol	40	12
Lovastatin	Lovastatin	40	11
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Diazepam	Diazepam	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	12
Acyclovir	Acyclovir	36	15
Buspirone Hcl	Buspirone Hcl	36	12
Celecoxib	Celecoxib	35	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	34	suppressed
Benazepril Hcl	Benazepril Hcl	34	11
Premarin	Estrogens, Conjugated	34	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	33	suppressed
Azithromycin	Azithromycin	32	24
Propranolol Hcl	Propranolol Hcl	32	suppressed
Levetiracetam	Levetiracetam	31	suppressed
Finasteride	Finasteride	30	suppressed
Methocarbamol	Methocarbamol	30	suppressed
Cephalexin	Cephalexin	29	25
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Prednisone	Prednisone	29	21
Valacyclovir	Valacyclovir Hcl	28	12
Valsartan	Valsartan	28	11
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	27	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Lidocaine	Lidocaine	27	11
Mounjaro	Tirzepatide	27	suppressed
Naproxen	Naproxen	27	14
Tramadol Hcl	Tramadol Hcl	27	14
Buprenorphine	Buprenorphine	26	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Myrbetriq	Mirabegron	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Eszopiclone	Eszopiclone	23	suppressed
Glipizide	Glipizide	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	19
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Hydrocortisone	Hydrocortisone	21	12
Pregabalin	Pregabalin	21	suppressed
Amoxicillin	Amoxicillin	20	16
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	18
Irbesartan	Irbesartan	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Nystatin	Nystatin	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Estradiol (Once Weekly)	Estradiol	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Fentanyl	Fentanyl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Belbuca	Buprenorphine Hcl	14	suppressed
Fosinopril Sodium	Fosinopril Sodium	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nystop	Nystatin	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Concerta	Methylphenidate Hcl	11	suppressed
Linzess	Linaclotide	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error